| APC | Adenomatous polyposis Coli |
| αMCA | α-muricholic acid |
| βMCA | β-muricholic acid |
| BA | Bile acid |
| CA | Cholic acid |
| CDCA | Chenodeoxycholic acid |
| CNTL | Control diet |
| CYP7A1 | Cytochrome P450 7A1 |
| DCA | Deoxycholic acid |
| FGF15/19 | Fibroblast growth factor 15/19 |
| FGFR4 | Fibroblast growth factor receptor-4 |
| FXR | Farnesoid X receptor |
| FXRE | Farnesoid X receptor element |
| G | Glycine conjugated |
| HNF4α | Hepatocyte nuclear factor 4α |
| LA | Linoleic acid |
| IBABP | Ileac bile acid-binding protein |
| LCA | Lithocholic acid |
| MDCA | Murideoxycholic acid |
| MYTG | Methionine-tyrosine-threonine-glycine |
| LRH-1 | Liver-related homolog-1 |
| n-6HFD | Omega-6 high-fat diet |
| NAFLD | Nonalcoholic fatty liver disease |
| PPARγ1−2 | Peroxisome proliferator-activated receptor-γ1 and -γ2 |
| PUFA | Polyunsaturated fatty acid |
| SFA | Saturated fatty acid |
| SHP | Small heterodimer protein |
| T | Taurine conjugated |
| T-CA | Taurine-cholic acid |
| T-CDCA | Taurine-chenodeoxycholic acid |
| T-βMCA | Taurine-β-muricholic acid |
| UDCA | Ursodeoxycholic acid |
| WT | Wild type |
| %E | Percent energy |